These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28696038)

  • 21. PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment.
    Cugno M; Borghi A; Marzano AV
    Am J Clin Dermatol; 2017 Aug; 18(4):555-562. PubMed ID: 28236224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
    De Souza A; Solomon GE; Strober BE
    Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hidradenitis suppurativa and chromosomal abnormalities: a case report and systematic review of the literature.
    Shah M; Sachdeva M; Melendez-Gonzalez M; Piguet V; Sayed C
    Int J Dermatol; 2021 Mar; 60(3):261-271. PubMed ID: 33599294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
    Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
    Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dowling-Degos disease and Verneuil disease].
    Balus L; Fazio M; Amantea A; Menaguale G
    Ann Dermatol Venereol; 1993; 120(10):705-8. PubMed ID: 8161103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The deregulation of NOTCH pathway, inflammatory cytokines, and keratinization genes in two Dowling-Degos disease patients with hidradenitis suppurativa.
    Cortez Cardoso Penha R; Cortez de Almeida RF; Câmara Mariz J; Brewer Lisboa L; do Nascimento Barbosa L; Souto da Silva R
    Am J Med Genet A; 2020 Nov; 182(11):2662-2665. PubMed ID: 33200913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAPA spectrum disorders.
    Genovese G; Moltrasio C; Garcovich S; Marzano AV
    G Ital Dermatol Venereol; 2020 Oct; 155(5):542-550. PubMed ID: 32618443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.
    Guillem P; Mintoff D; Kabbani M; Cogan E; Vlaeminck-Guillem V; Duquesne A; Benhadou F
    Front Immunol; 2022; 13():883811. PubMed ID: 35720358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful use of brachytherapy for a severe hidradenitis suppurativa variant.
    Paul S; Bach D; LeBoeuf NR; Devlin PM; Lipworth AD
    Dermatol Ther; 2016 Nov; 29(6):455-458. PubMed ID: 27425163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Remission of Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome.
    Brokamp G; Bechtel M; Chung C
    Cutis; 2023 Jun; 111(6):E2-E6. PubMed ID: 37487120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gene dysfunction module reveals the underlying pathogenesis of hidradenitis suppurativa: An update.
    Li X; Jiang L; Huang Y; Ren Z; Liang X; Wang P
    Australas J Dermatol; 2020 Feb; 61(1):e10-e14. PubMed ID: 31266094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis.
    Tricarico PM; Boniotto M; Genovese G; Zouboulis CC; Marzano AV; Crovella S
    Front Immunol; 2019; 10():892. PubMed ID: 31105704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes.
    Saternus R; Schwingel J; Müller CSL; Vogt T; Reichrath J
    J Transl Autoimmun; 2020; 3():100071. PubMed ID: 33305249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.
    Soria A; Canoui-Poitrine F; Wolkenstein P; Poli F; Gabison G; Pouget F; Viallette C; Revuz J
    Dermatology; 2009; 218(2):134-5. PubMed ID: 19060466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?
    Garzorz N; Papanagiotou V; Atenhan A; Andres C; Eyerich S; Eyerich K; Ring J; Brockow K
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):141-3. PubMed ID: 25070077
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.